Stocks
OpGen IncOPGN
HealthcareDiagnostics & Research
A molecular diagnostics company focused on rapid testing for infectious diseases and antimicrobial resistance. Its portfolio includes FDA-cleared tests for urinary tract infections and sepsis pathogens, with a shift toward digital health tools. Investors track it for its role in the antibiotic stewardship market and its small-cap volatility.
Congressional Interest in OpGen Inc (OPGN)
1 member of Congress has disclosed 1 trade in OpGen Inc (OPGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading OPGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-01-15 | MICHAEL T. MCCAUL | buy | $1K-$15K |